Inhaled Nitric Oxide (INO) In Hypoxic Respiratory Failure
Status:
Withdrawn
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This Phase 3, Double-blind, Randomized, Placebo controlled, multicenter study is to confirm
the efficacy of inhaled nitric oxide for the management of hypoxic respiratory failure
associated with pulmonary hypertension in preterm infants.
Study subjects will be administered either inhaled nitric oxide or placebo to determine if
there is a change in oxygenation.